Andere Kunden interessierten sich auch für
![Indoor Exposure to Fine Particulate Matter and Practical Mitigation Approaches]( "Indoor Exposure to Fine Particulate Matter and Practical Mitigation Approaches")
Indoor Exposure to Fine Particulate Matter and Practical Mitigation Approaches32,99 €![Indoor Air Pollution: Prenatal Exposure to Indoor Particulate Matter (PM2.5) and Volatile Organic Compounds (VOC) in Masaiti and Ndola, Zamb]( "Indoor Air Pollution: Prenatal Exposure to Indoor Particulate Matter (PM2.5) and Volatile Organic Compounds (VOC) in Masaiti and Ndola, Zamb")
Indoor Air Pollution: Prenatal Exposure to Indoor Particulate Matter (PM2.5) and Volatile Organic Compounds (VOC) in Masaiti and Ndola, Zamb50,99 €![Principles for the Assessment of Risks to Human Health from Exposure to Chemicals - Environmental Health Criteria Series No. 210]( "Principles for the Assessment of Risks to Human Health from Exposure to Chemicals - Environmental Health Criteria Series No. 210")
Principles for the Assessment of Risks to Human Health from Exposure to Chemicals - Environmental Health Criteria Series No. 21032,99 €![Principles for Evaluating Health Risks to Reproduction Associated with Exposure to Chemicals: Environmental Health Criteria Series No. 225]( "Principles for Evaluating Health Risks to Reproduction Associated with Exposure to Chemicals: Environmental Health Criteria Series No. 225")
Principles for Evaluating Health Risks to Reproduction Associated with Exposure to Chemicals: Environmental Health Criteria Series No. 22546,99 €![Exposure of the American People to Iodine-131 from Nevada Nuclear-Bomb Tests]( "Exposure of the American People to Iodine-131 from Nevada Nuclear-Bomb Tests")
Exposure of the American People to Iodine-131 from Nevada Nuclear-Bomb Tests54,99 €![Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products]( "Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products")
Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products53,99 €![Metrics That Matter for Population Health Action]( "Metrics That Matter for Population Health Action")
Metrics That Matter for Population Health Action56,99 €
"The U.S. Environmental Protection Agency (EPA) defines PM as a mixture of extremely small particles and liquid droplets comprising a number of components, including 'acids (such as nitrates and sulfates), organic chemicals, metals, soil or dust particles, and allergens (such as fragments of pollen and mold spores)'. The health effects of outdoor exposure to particulate matter (PM) are the subject of both research attention and regulatory action. Although much less studied to date, indoor exposure to PM is gaining attention as a potential source of adverse health effects. Indoor PM can originate from outdoor particles and also from various indoor sources, including heating, cooking, and smoking. Levels of indoor PM have the potential to exceed outdoor PM levels. Understanding the major features and subtleties of indoor exposures to particles of outdoor origin can improve our understanding of the exposure--response relationship on which ambient air pollutant standards are based. The EPA's Indoor Environments Division commissioned the National Academies of Sciences, Engineering, and Medicine to hold a workshop examining the issue of indoor exposure to PM more comprehensively and considering both the health risks and possible intervention strategies. Participants discussed the ailments that are most affected by particulate matter and the attributes of the exposures that are of greatest concern, exposure modifiers, vulnerable populations, exposure assessment, risk management, and gaps in the science. This report summarizes the presentations and discussions from the workshop"--
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.